A 23-Year-Olf Man With Progressibe Asymmetric Weakness and Numbness
Neurol 100:674-682, Kaplan,E.H.,et al, 2023
Inflammatory Demyelinating Polyneuropathy Versus Leptomeningeal Disease Following Ipilimumab
J Immunother Cancer 6:11, Cafuir, L.,et al, 2018
Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 76:294-300, Cortese,I.,et al, 2011
Plasma Exchange in Neuroimmunological Disorders: Part 2. Treatment of Neuromuscular Disorders
Arch Neurol 63:1066-1071, Lehmann,H.C.,et al, 2006
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Clinical Spectrum of Chronic Acquired Demyelinating Polyneuropathies
Muscle & Nerve 24:311-324, Saperstein,D.S.,et al, 2001
CIDP:Clinical Features & Responses to Trtm in 67 Consecutive Pts with/without a Monoclonal Gammopathy
Neurol 48:321-328, Gorson,K.G.,et al, 1997
Intravenous Immune Globulin Therapy for Neurologic Diseases
Ann Int Med 126:721-730, Dalakas,M.C., 1997
Chronic Inflammatory Demyelinating Polyradiculoneuropathy:Unusual Clinical Features and Therapeutic Responses
Neurol 46:1206-1212, Midroni,G.&Dyck,P.J., 1996
Plasma Exchange and Intravenous Immunoglobulin Treatment of Neuromuscular Disease
Ann Neurol 35:260-268, Thornton,C.A.&Griggs,R.C., 1994
Neurologic Manifestations of HIV Infection
Ann Int Med 121:769-785, Simpson,D.M.&Tagliati,M., 1994
"Chronic Sensory Demyelinating Neuropathy":CIDP Presenting as a Pure Sensory Neuropathy
JNNP 55:677-680, Oh,S.J.,et al, 1992
Immunologic Aspects of Neurological and Neuromuscular Diseases
JAMA 268:2918-2922, Zweiman,B.&Levinson,A.I., 1992
AIDS and the Nervous System
JAMA 261:2396-2399, Dalakas,M.,et al, 1989
A 64-Year-Old Man with Multiple Cranial Neuropathies
Neurol 97:e215-e221, Lefland, A.,et al, 2021
A 57-Year-Old Woman with Progressive Ataxia and Falls
Neurol 95:650-656, Badahdah, A., 2020
Clinical Reasoning: A 49-year-old man with Progressive Numbness, Weakness, and Evidence of Leptomeningeal Enhancement
Neurol 90:e90-e93, Lovett, A.,et al, 2018
A Comparative Study of CIDP in a Cohort of HIV-Infected and HIV-Uninfected Patients
Neurol Neuroimmunol Neuroinflamm 4:e315, Moodley, K.,et al, 2017
CIDP Diagnostic Pitfalls and Perception of Treatment Benefit
Neurol 85:498-504, Allen, J.A. & Lewis, R.A., 2015
Evidence-based Guideline: Intravenous Immunoglobulin in the Treatment of Neuromascular Disorders
Neurol 78:1009-1015, Patwa,H.S.,et al, 2012
Rituximab in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Report of 13 Cases and Review of the Literature
JNNP 82:306-308, Benedetti,L.,et al, 2011
Spectrum of Paraneoplastic Disease Associated With Lymphoma
Neurol 76:705-710, Briani,C.,et al, 2011
Natalizumab Treatment in a Patient With Chronic Inflammatory Demyelinating Polyneuropathy
Arch Neurol 67:881-883, Wolf,C., et al, 2010
Chronic Inflammatory Demyelinating Polyneuropathy: Etiology, Clinical Features, and Diagnosis
UpToDate, Sept, Lewis, R., 2010
Whole-Body Magnetic Resonance Neurography
NEJM 361:538-539, Yamashita,T.,et al, 2009
Long-Term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-a-Blocker Therapy
JAMA Neurol 66:490-497, Lozeron, P.,et al, 2009
Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008
Classifications and Treatment Responses in Chronic Immune-Mediated Demyelinating Polyneuropathy
Neurol 68:1622-1629, Tackenberg,B.,et al, 2007
Long Term Prognosis of Chronic Inflammatory Demyelinating Polyneuropathy: A Five Year Follow Up of 38 Cases
JNNP 77:66-70, Kuwabara,S.,et al, 2006
Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Methotrexate
JNNP 77:544-547, Fialho,D.,et al, 2006
Concomitant Chronic Inflammatory Demyelinating Polyneuropathy and Myasthenia Gravis Following Cytomegalovirus Infection
J Neurol Sci 240:103-106, Mori, M.,et al, 2006
Treatment of Chronic Inflamatory Demyelinating Polyneuropathy With High-Dose Intermittent Intravenous Methylprednisolone
Arch Neurol 62:249-254, Lopate, G., et al, 2005
Chronic Inflammatory Demyelinating Polyradiculoneuropathy: MRI Study of Brain and Spinal Cord
Neurol 64:914-916, Laura, M., et al, 2005
Chronic Inflammatory Demyelinating Polyneuropathy
NEJM 352:1343-1356, Koller,H.,et al, 2005
Clinical and Electrophysiologic Correlates of IVIg Responsiveness in CIDP
Neurol 64:1471-1475, Iijima,M.,et al, 2005
Neuropathy Resembling CIDP in Patients Receiving Tumor Necrosis Factor-a Blockers
Neurol 64:1468-1470, Richez,C.,et al, 2005
Lymphoma and Peripheral Neuropathy: A Clinical Review
Muscle Nerve 31:301-313, Kelly,J.J. &Karcher,D.S., 2005
Efficacy of Mycophenolate Mofetil in Patients with Chronic Immune Demyelinating Polyneuropathy
NEruol 63:715-717, Gorson,K.C.,et al, 2004
Clinicopath Conf., Chronic Inflammatory Demyelinating Polyneuropathy
NEJM 348:735-743, Case 6-2003, 2003
Chronic Inflammatory Demyelinating Polyneuropathy Presenting with Features of GBS
Neurol 58:979-982, Mori,K.,et al, 2002
High-dose Cyclophosphamide Without Stem-cell Rescue for Refractory CIDP
Neurol 58:1856-1858, Brannagan,T.H.,et al, 2002
Randomized Controlled Trial of IVIg in Untreated Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Neurol 56:445-449, Mendell,J.R.,et al, 2001
Randomized Controlled Trial of Intravenous Immunoglobulin Versus Oral Prednisolone in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Ann Neurol 50:195-201, Hughes,R.,et al, 2001
Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Hypertrophy of Multiple Cranial Nerves and Spinal Roots in Chronic Inflammatory Demyelinating Neuropathy
JNNP 67:685-687, Duarte,J.,et al, 1999
Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999
Procainamide-Induced Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Neurol 50:824-825, Erdem,S.,et al, 1998
Clinicopath Conf
Chronic Inflammatory Demyelinating Polyneuropathy, Case 13-1998, NEJM 338:1212-1219998., , 1998